Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients.

van Boxtel, Wim; Verhaegh, Gerald W; van Engen-van Grunsven, Ilse A; van Strijp, Dianne; Kroeze, Leonie I; Ligtenberg, Marjolein J; van Zon, Hans B; Hendriksen, Yara; Keizer, Diederick; van de Stolpe, Anja; Schalken, Jack A; van Herpen, Carla M

van Boxtel, Wim; Verhaegh, Gerald W; van Engen-van Grunsven, Ilse A; van Strijp, Dianne; Kroeze, Leonie I; Ligtenberg, Marjolein J; van Zon, Hans B; Hendriksen, Yara; Keizer, Diederick; van de Stolpe, Anja; Schalken, Jack A; van Herpen, Carla M.

Afiliación

van Boxtel W; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Verhaegh GW; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Engen-van Grunsven IA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Strijp D; Philips Research, Eindhoven, The Netherlands.
Kroeze LI; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Ligtenberg MJ; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Zon HB; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Hendriksen Y; Philips Research, Eindhoven, The Netherlands.
Keizer D; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van de Stolpe A; Molecular Pathway Diagnostics, Philips Healthworks, Eindhoven, The Netherlands.
Schalken JA; Philips Research, Eindhoven, The Netherlands.
van Herpen CM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.

Int J Cancer ; 146(11): 3196-3206, 2020 06 01.

Article en En | MEDLINE | ID: mdl-31745978

Asunto(s)

Antagonistas de Andrógenos/uso terapéutico; Receptores Androgénicos/deficiencia; Receptores Androgénicos/metabolismo; Neoplasias de las Glándulas Salivales/tratamiento farmacológico; 3-Oxo-5-alfa-Esteroide 4-Deshidrogenasa/genética; Adulto; Anciano; Miembro C3 de la Familia 1 de las Aldo-Ceto Reductasas/genética; Supervivencia sin Enfermedad; Femenino; Humanos; Masculino; Proteínas de la Membrana/genética; Persona de Mediana Edad; Receptor ErbB-2/genética; Receptores Androgénicos/genética; Conductos Salivales/patología; Neoplasias de las Glándulas Salivales/patología; Esteroide 17-alfa-Hidroxilasa/genética

Palabras clave

androgen receptor antagonists; computational biology; drug resistance; neoplasm; salivary duct carcinoma; salivary gland neoplasms

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de las Glándulas Salivales / Receptores Androgénicos / Antagonistas de Andrógenos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google